SCHEMBL6971747

SCHEMBL6971747

C#CC(O)c1ccc(N(C)C)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.46
TSHR P16473 5/20 0.46
ALOX15 P16050 3/20 0.46
HSD17B10 Q99714 2/20 0.46
GAA P10253 4/20 0.42
ATM Q13315 1/20 0.42
SLC2A1 P11166 2/20 0.41
L3MBTL1 Q9Y468 2/20 0.41
KDM4E B2RXH2 1/20 0.40
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
MAPT P10636 3/20 0.39
HPGD P15428 1/20 0.39
CYP3A4 P08684 3/20 0.38
MAPK1 P28482 3/20 0.38
TDP1 Q9NUW8 2/20 0.38
TP53 P04637 1/20 0.38
CYP1A2 P05177 1/20 0.38
PHLPP2 Q6ZVD8 1/20 0.38
HBB P68871 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9547906 0.83 ALDH1A1 (0.50) ALDH1A1TSHRALOX15HSD17B10GAA
SCHEMBL29184903 0.82 ESR1 (0.46) TSHR
SCHEMBL1578958 0.79 TSHR (0.54) ALDH1A1TSHRALOX15HSD17B10GAA
SCHEMBL2381152 0.79 GAA (0.42) ALDH1A1TSHRALOX15HSD17B10GAA
SCHEMBL9130944 0.79 ALDH1A1 (0.49) ALDH1A1TSHRGAAL3MBTL1KDM4E
SCHEMBL7203087 0.76 TYR (0.40) ALDH1A1GAAKDM4EMAPK1
SCHEMBL7199129 0.76 CHRNA7 (0.39) ALDH1A1TSHRMAPTTDP1FFAR1
SCHEMBL13917807 0.75 ALDH1A1 (0.58) ALDH1A1TSHRALOX15HSD17B10GAA
SCHEMBL142069 0.75 ALDH1A1 (0.58) ALDH1A1TSHRALOX15HSD17B10GAA
SCHEMBL23745916 0.75 ESR1 (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1149092-B1 4- AND 5-ALKYNYLOXINDOLES AND 4- AND 5-ALKENYLOXINDOLES HOFFMANN LA ROCHE (CH) 2003-10-29 EP disclosed
US-6313310-B1 JUN N-TERMINAL KINASE (JNK) ENZYME INHIBITORS; ANTIINFLAMMATORY AGENTS; RHEUMATIC ARTHRITIS AND NEURO-DEGENERATIVE DISEASE TREATMENT HOFFMANN-LA ROCHE INC. 2001-11-06 US disclosed
EP-1149092-A2 4- AND 5-ALKYNYLOXINDOLES AND 4- AND 5-ALKENYLOXINDOLES F. HOFFMANN-LA ROCHE AG (CH) 2001-10-31 EP disclosed
WO-2000035906-A2 4- AND 5-ALKYNYLOXINDOLES AND 4- AND 5-ALKENYLOXINDOLES F. HOFFMANN-LA ROCHE AG (CH) 2000-06-22 WO disclosed
EP-0476645-B1 Calcium uptake inhibitors MERRELL DOW PHARMA (US) 1995-09-06 EP disclosed
US-5409942-A Administering 1-phenyl-3-aryl-2-propyne-1-ones compounds MERRELL DOW PHARMACEUTICALS INC. (US) 1995-04-25 US disclosed
US-5223518-A Controlling intake in leukocytes and platelets MERRELL DOW PHARMACEUTICALS INC. (US) 1993-06-29 US disclosed
EP-0476645-A1 Calcium uptake inhibitors MERRELL DOW PHARMACEUTICALS INC. (US) 1992-03-25 EP disclosed